ClinicalTrials.gov record
A Safety Study Of Pregabalin In Fibromyalgia
ClinicalTrials.gov ID: NCT00282997
Public ClinicalTrials.gov record NCT00282997. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week, Open-Label, Safety Trial Of Pregabalin In Patients With Fibromyalgia
Study identification
- NCT ID
- NCT00282997
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Industry
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Interventions
- pregabalin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2006
- Primary completion
- Not listed
- Completion
- Sep 30, 2006
- Last update posted
- Jan 21, 2021
2006
United States locations
- U.S. sites
- 72
- U.S. states
- 29
- U.S. cities
- 72
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Little Rock | Arkansas | — | — |
| Pfizer Investigational Site | Fresno | California | — | — |
| Pfizer Investigational Site | La Jolla | California | — | — |
| Pfizer Investigational Site | Northridge | California | — | — |
| Pfizer Investigational Site | Pismo Beach | California | — | — |
| Pfizer Investigational Site | Sacramento | California | — | — |
| Pfizer Investigational Site | San Diego | California | — | — |
| Pfizer Investigational Site | Walnut Creek | California | — | — |
| Pfizer Investigational Site | Newark | Delaware | — | — |
| Pfizer Investigational Site | DeLand | Florida | — | — |
| Pfizer Investigational Site | Gainesville | Florida | — | — |
| Pfizer Investigational Site | Hollywood | Florida | — | — |
| Pfizer Investigational Site | Melbourne | Florida | — | — |
| Pfizer Investigational Site | Ocala | Florida | — | — |
| Pfizer Investigational Site | Palm Harbor | Florida | — | — |
| Pfizer Investigational Site | Sunrise | Florida | — | — |
| Pfizer Investigational Site | Tampa | Florida | — | — |
| Pfizer Investigational Site | West Palm Beach | Florida | — | — |
| Pfizer Investigational Site | Gurnee | Illinois | — | — |
| Pfizer Investigational Site | Moline | Illinois | — | — |
| Pfizer Investigational Site | Indianapolis | Indiana | — | — |
| Pfizer Investigational Site | Dubuque | Iowa | — | — |
| Pfizer Investigational Site | Prairie Village | Kansas | — | — |
| Pfizer Investigational Site | Pratt | Kansas | — | — |
| Pfizer Investigational Site | Lexington | Kentucky | — | — |
| Pfizer Investigational Site | Kenner | Louisiana | — | — |
| Pfizer Investigational Site | Metairie | Louisiana | — | — |
| Pfizer Investigational Site | North Dartmouth | Massachusetts | — | — |
| Pfizer Investigational Site | Watertown | Massachusetts | — | — |
| Pfizer Investigational Site | Worcester | Massachusetts | — | — |
| Pfizer Investigational Site | Chaska | Minnesota | — | — |
| Pfizer Investigational Site | Saint Paul | Minnesota | — | — |
| Pfizer Investigational Site | Jefferson City | Missouri | — | — |
| Pfizer Investigational Site | Kansas City | Missouri | — | — |
| Pfizer Investigational Site | St Louis | Missouri | — | — |
| Pfizer Investigational Site | Lincoln | Nebraska | — | — |
| Pfizer Investigational Site | Morristown | New Jersey | — | — |
| Pfizer Investigational Site | Albany | New York | — | — |
| Pfizer Investigational Site | Endwell | New York | — | — |
| Pfizer Investigational Site | New York | New York | — | — |
| Pfizer Investigational Site | West Seneca | New York | — | — |
| Pfizer Investigational Site | Asheville | North Carolina | — | — |
| Pfizer Investigational Site | Hickory | North Carolina | — | — |
| Pfizer Investigational Site | Raleigh | North Carolina | — | — |
| Pfizer Investigational Site | Salisbury | North Carolina | — | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | — | — |
| Pfizer Investigational Site | Minot | North Dakota | — | — |
| Pfizer Investigational Site | Cincinnati | Ohio | — | — |
| Pfizer Investigational Site | Dayton | Ohio | — | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | — | — |
| Pfizer Investigational Site | Bethlehem | Pennsylvania | — | — |
| Pfizer Investigational Site | Norristown | Pennsylvania | — | — |
| Pfizer Investigational Site | Goose Creek | South Carolina | — | — |
| Pfizer Investigational Site | Mt. Pleasant | South Carolina | — | — |
| Pfizer Investigational Site | Myrtle Beach | South Carolina | — | — |
| Pfizer Investigational Site | Summerville | South Carolina | — | — |
| Pfizer Investigational Site | Knoxville | Tennessee | — | — |
| Pfizer Investigational Site | Milan | Tennessee | — | — |
| Pfizer Investigational Site | Nashville | Tennessee | — | — |
| Pfizer Investigational Site | Bedford | Texas | — | — |
| Pfizer Investigational Site | Georgetown | Texas | — | — |
| Pfizer Investigational Site | Houston | Texas | — | — |
| Pfizer Investigational Site | Killeen | Texas | — | — |
| Pfizer Investigational Site | Lake Jackson | Texas | — | — |
| Pfizer Investigational Site | San Antonio | Texas | — | — |
| Pfizer Investigational Site | Salt Lake City | Utah | — | — |
| Pfizer Investigational Site | Woodstock | Vermont | — | — |
| Pfizer Investigational Site | Virginia Beach | Virginia | — | — |
| Pfizer Investigational Site | Everett | Washington | — | — |
| Pfizer Investigational Site | Spokane | Washington | — | — |
| Pfizer Investigational Site | Tacoma | Washington | — | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00282997, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 21, 2021 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00282997 live on ClinicalTrials.gov.